Research

One prominent commitment of Hospital Medicine is to the development of evidence-based inpatient medicine practices. Through development of publications such as the Consult Manual, Hospital Medicine physicians have increased the exposure of internal medicine residents and medical students to principles of quality inpatient care. Their unique focus on inpatient care affords Hospital Medicine physicians a practical experience base on which to build sound and sensible guidelines for management.

 

Listed below are recent publications by our Hospitalist members:

  • Arroyo-Plasencia A , Reno H. Spot Diagnosis.  Missouri Hospitalist, Issue 47: April-June, 2013.
  • Management of imatinib resistant patients with chronic myeloid leukemia -Pavan Kumar Bhamidipati, Hagop Kantarjian, Jorge Cortes, A. Megan Cornelison, and Elias Jabbour. Therapeutic Advances in Hematology. December 14, 2012 14;4(2):103–17. doi:10.1177/2040620712468289
  • Arroyo-Plasencia A, Murad F, Reno H, Freer JM. 9 Lives. Hospital Medicine 2013. Annual Conference of the Society of Hospital Medicine; May, 2013
  • ASH 2013 submissions “Psoas Cross-Sectional Area As Radiographic Measure Of Sarcopenia Does Not Predict Overall Survival In Multiple Myeloma” a retrospective study under  Dr Tanya Wildes, Division of Medical oncology, Washington University School of Medicine-submitted for  ASH-2013- Pavan Kumar Bhamidipati
  • Reno,Hilary E L, Cathleen Brethauer, Denise Spear, Richard Knaup, Bradley P. Stoner. Enhanced oropharyngeal and rectal testing for Neisseria gonorrhoeae and Chlamydia trachomatis at a public STI clinic. STI and AIDS World Congress, July, 2013.
  • Wang TF, Milligan PE, Wong CA, Deal EN, Thoelke MS, Gage BF. Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. Thromb Haemost. 2013 Oct 17;111(2).
  • Sabo, Michelle, Hilary Reno, Rachel Presti, and Bradley Stoner. Characterization of Neisseria gonorrhea and Chylamydia trachomatisinfections in patients living with HIV. STI and AIDS World Congress, July, 2013. 
  • Yeung M, Kerrigan J, Sodhi S, Huang PH, Novak E, Maniar H, Zajarias A. "Racial Differences in Rates of Aortic Valve Replacement in Patients With Severe Aortic Stenosis." American Journal of Cardiology 2013;112:991-995.
  • Sabo, Michelle, Hilary Reno, Rachel Presti, and Bradley Stoner. Characterization of Neisseria gonorrhea and Chylamydia trachomatisinfections in patients living with HIV. Infectious Disease Society of America, October, 2013.
  • Kerrigan J, Makan M. "An Echocardiographic Abnormality in an HIV Patient with Coronary Disease." Heart 2013; in-press.
  • Wang TF, Wong CA, Milligan PE, Thoelke MS, Woeltje KF, Gage BF. Thromb Res. Risk factors for inpatient venous thromboembolism despite thromboprophylaxis 2013 Sep 16
  • Bilal S, Quianzon C, Quje E, Alfreijat M, Yazaji E. Ectopic ACTH syndrome leading to the diagnosis of Small Cell lung Cancer. Poster presentation at ACP meeting; Baltimore MD, 2012
  • Chapter 63: Personalized Medicine and Targeted Therapy of Leukemia.” - Pavan Kumar Bhamidipati, Elias Jabbour, Jorge Cortes.  In Principles of Molecular Diagnostics and Personalized Cancer Medicine. 1 Har/Psc. Lippincott Williams & Wilkins, n.d. ISBN 978-1-4511-3197-0
  • “Chapter 7: Frontline Therapy.” - Pavan Kumar Bhamidipati and Elias Jabbour. In Chronic Myeloid Leukemia: From Daily Management to Complicated Issues. Nova Publishers; 2014. ISBN 978-1-62948-971 
  • Pongruangporn M, Ritchie DJ, Lu D, Marschall J. Case Rep Infect Dis. 2011;2011:356370
  • “Chapter 8: Management of Tyrosine Kinase Inhibitors Resistance.” - Pavan Kumar Bhamidipati and Elias Jabbour. In Chronic Myeloid Leukemia: From Daily Management to Complicated Issues. Nova Publishers; 2014. ISBN 978-1-62948-971-1
  • “Protective Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients Is Influenced by Conditioning Regimen” – S Manjappa and PK Bhamidipati et al., Biology of Blood and Marrow Transplantation - 14 October 2013 (10.1016/j.bbmt.2013.10.003)
  • Akhter E, Bilal S, Haque U. Prevalence of arthritis in India and Pakistan: a review. Rheumatol Int 2011
  • Epstein-Barr Virus–Induced CD30-Positive Diffuse Large B-Cell Lymphoma in a Patient With Mixed-Phenotypic Leukemia Treated With Clofarabine - Pavan Kumar Bhamidipati, Elias Jabbour, Sergej Konoplev, Zeev Estrov, Jorge Cortes, Naval Daver Clinical Lymphoma Myeloma and Leukemia 17 December 2012 (Article in Press DOI: 10.1016/j.clml.2012.10.002)
  • An atypical presentation with diagnostic challenge and unapproachable presentation of a large cell Neuroendocrine cancer of lung: A Case Report and review of literature -  published in  “Lung cancer international”- Volume 2011 (2011), Article ID 912098, doi:10.4061/2011/912098 Pavan Kumar Bhamidipati
  • “Chapter 63: Personalized Medicine and Targeted Therapy of Leukemia.” - Pavan Kumar Bhamidipati, Elias Jabbour, Jorge Cortes.  In Principles of Molecular Diagnostics and Personalized Cancer Medicine. 1 Har/Psc. Lippincott Williams & Wilkins, n.d. ISBN 978-1-4511-3197-0
  • “Haploidentical Peripheral Blood Stem Cell Transplantation Using Non-Myeloablative Conditioning With Post-Transplant Cyclophosphamide Regimen Is Safe and Is Associated With Very Encouraging Post-Transplant Outcomes”  under Dr Romee Rizwan and Dr DiPersio, Division of Medical oncology, Washington University School of Medicine –ASH-2013; Abstract: 4532 Pavan Kumar Bhamidipati 
  • Bilal S, Campbell W. Infective Endocarditis of Patent Foreman Ovale Closure Device. Poster presentation at ACP meeting; Baltimore MD, 2012
  • “Predicting Autologous Stem Cell Mobilization Failure In Hematologic Malignancies”  under Dr DiPersio and Dr Keith-Stockerl Goldstein, Division of Medical oncology, Washington University School of Medicine - ASH-2013; Abstract: 2034 Pavan Kumar Bhamidipat
  • Pongruangporn M, Ajenjo MC, Russo AJ, McMullen KM, Robinson C, Williams RC, Warren DK. Infect Control Hosp Epidemiol. 2013 Feb;34(2):184-9
  • ASBMT 2013 submissions "T-Cell Replete Peripheral Blood Stem Cell Transplantation after Non-Myeloablative Conditioning with Post-Transplant High Dose Cyclophosphamide Is Safe and Is Associated with Acceptable Outcomes"  underDr Romee Rizwan and Dr DiPersio, Division of Medical oncology, Washington University School of Medicine – submitted for ASBMT-2013- Pavan Kumar Bhamidipati
  • Alfreijat M, Bilal S. Catastrophic Antiphospholipid Syndrome: an extensive skin necrosis. Poster presentation at ACP meeting; Baltimore MD, 2012

Please contact Hospital Medicine at (314) 362-1700, if you are interested in organizing a prospective or retrospective trial at Barnes-Jewish Hospital or if you need assistance.

More Information